Semaglutide is a potent glucagon-like peptide-1 (GLP-1) receptor agonist used primarily in the management of type 2 diabetes mellitus.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that plays a crucial role in the management of type 2 diabetes mellitus. It functions by mimicking the action of the incretin hormone GLP-1, which enhances insulin secretion in response to meals, thereby aiding in the regulation of blood glucose levels.
In addition to its glucose-lowering effects, semaglutide has been shown to promote weight loss, making it a valuable option for patients with obesity-related metabolic disorders. Its mechanism involves delaying gastric emptying and reducing appetite, contributing to its efficacy in weight management.
Semaglutide is typically administered via subcutaneous injection, allowing for sustained release and prolonged action in the body. This pharmacokinetic profile supports its use in once-weekly dosing regimens, improving patient adherence and convenience.
Clinical studies have demonstrated semaglutide's effectiveness in reducing HbA1c levels and achieving significant weight reduction, with a favorable safety profile. Common side effects include gastrointestinal disturbances, such as nausea and diarrhea, which are generally transient and diminish over time.
As a compounding pharmacy, Bayview Pharmacy offers customized formulations of semaglutide to meet specific patient needs, ensuring optimal therapeutic outcomes. Healthcare providers may consider semaglutide for patients who require additional glycemic control or those who benefit from its weight loss properties.
Each of these is compounded to order at our Warwick, Rhode Island pharmacy and requires a prescription.
A sample of preparations from our formulary. Strengths and dose forms are customised to the prescription.
Sublingual semaglutide is a compounded liquid form of semaglutide, a GLP-1 receptor agonist, taken as drops held under the tongue. Bayview prepares it to the strength your provider orders. It is prescription-only and is not FDA-approved.
No. The FDA-approved semaglutide products are the injections (Ozempic, Wegovy) and an oral tablet (Rybelsus); there is no FDA-approved sublingual form. A compounded preparation is not reviewed by the FDA, and whether it can be compounded for you is decided by your provider and the pharmacy.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.